Investor Relations


Frequently Asked Questions

On December 26, 2017, NorthStar Healthcare Income, Inc. (the Company) filed a Form 8-K with the Securities and Exchange Commission (SEC) in which the Company reported its estimated net asset value per share as of June 30, 2017 and also announced changes to its advisory agreement, distribution rate and share repurchase program. Since this filing, the Company has received questions from various of its stakeholders regarding this filing. Set forth below are the Company’s responses to certain of the more frequently asked questions. For additional information regarding the Company, please see the Company’s filings with the SEC.

 FAQ  Download the Frequently Asked Questions PDF

This website is neither an offer to sell nor a solicitation of an offer to buy securities. An offering is made only by the prospectus. This website must be read in conjunction with the prospectus in order to fully understand all of the implications and risks of the offering of securities to which the prospectus relates. A copy of the prospectus must be made available to you in connection with any offering. No offering is made except by a prospectus filed with the Department of Law of the State of New York. Neither the Securities and Exchange Commission, the Attorney General of the State of New York nor any other state securities regulator has approved or disapproved of our common stock, determined if the prospectus is truthful or complete or passed on or endorsed the merits of this offering. Any representation to the contrary is a criminal offense. Consult the prospectus for suitability standards in your state. Securities offered through NorthStar Securities, LLC, member FINRA/SIPC, an affiliate of and the dealer manager for NorthStar Healthcare. NorthStar Securities, LLC is doing business as NorthStar BD Securities, LLC (DE) in the following states: FL, GA, TX and WA.